NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$11.13 USD
-0.38 (-3.30%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $11.14 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NVCR 11.13 -0.38(-3.30%)
Will NVCR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVCR
NovoCure (NVCR) Reports Q2 Earnings: What Key Metrics Have to Say
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
NVCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
NovoCure (NVCR) Soars 5.3%: Is Further Upside Left in the Stock?
What Makes NovoCure (NVCR) a New Buy Stock
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
Other News for NVCR
NovoCure: Cash Burn, A Costly Launch, And A Maturing Business Signal More Pain Ahead
Insider Buying: Christoph Brackmann Acquires 20,000 Shares of NovoCure Ltd (NVCR)
NovoCure's Wearable Oncology Edge And Compelling Valuation
Top 3 Health Care Stocks That May Explode In July
Wells Fargo Downgrades NovoCure (NVCR) with Significant Price Target Cut | NVCR Stock News